Why ERNA? Ernexa Therapeutics Inc. Analysis, Price & AI Insights | Whystock
ERNA
$3.40-0.41 (-10.82%)
Market OpenUpdated 9:50 AM EDT
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease.